September 2022 - Sverica Capital

Sverica Capital Management Announces Recapitalization of Synoptek by Quad-C Management

News

Index

Sverica Capital Management Announces Recapitalization of Synoptek by Quad-C Management

Irvine, CA – September 27, 2022 – Sverica Capital Management LP (“Sverica”) announced today that its portfolio company, Synoptek (or the “Company”), has sold a majority stake to investment firm Quad-C Management (or “Quad-C”). Sverica will retain a minority position as a result of the transaction.

Founded in 2001 and headquartered in Irvine, CA, Synoptek is a leading full-service business technology solutions provider. The Company partners with customers to envision, transform and evolve their businesses to achieve better results using technology. The Company’s global technology services implementation and management platform enables customers to accelerate their use of technology and reduce technology operating expenses.

Synoptek has experienced significant growth since Sverica’s initial investment in October 2015. Under Sverica’s ownership, Synoptek completed five strategic acquisitions which helped increase the Company’s delivery capacity in various geographies and meaningfully expanded its portfolio of services. Today, Synoptek employs over 1,000 technology professionals spanning 12 offices globally. The demand for Synoptek’s services is fueled by growing business dependence on technology and the widespread adoption of cloud platforms such as Microsoft Dynamics, Salesforce, ServiceNow, Azure, AWS, Microsoft 365, and Google G-Suite.

Frank Young, Managing Partner at Sverica, said, “Synoptek has accomplished a tremendous amount since we first joined forces with Tim to further scale the business. During our partnership, the Company experienced dramatic growth, built out a global footprint, and materially expanded its portfolio of service offerings, all of which were beneficial to customers. Tim, the management team, and the employees of Synoptek were great partners throughout. The Company is extremely well positioned for the future, and we look forward to continuing to retain a minority position under the leadership of the Company by Tim and Quad-C.”

Tim Britt, CEO of Synoptek, said, “Sverica became a valuable extension of our team. They had an immediate impact by initiating a pivotal discussion of service portfolio strategy and a shift to cloud-related services. They were great partners and provided important input on the overall direction of the Company which drove accelerated growth.”

“Synoptek and Sverica forged a strong partnership, and the Company’s expanded capabilities, expertise, and resources resulting from strategic investments made with Tim and the Synoptek team position the Company well to deliver valuable full-stack service to customers. We’re excited to continue supporting the Synoptek team as they embark on a new chapter in the Company’s growth,” said Ryan Harstad, Partner at Sverica.

About Synoptek

Synoptek is a global Business and Technology Consulting and Advisory firm that helps companies envision, transform, and evolve. As a Global Systems Integrator and managed Technology Services Provider, Synoptek partners with organizations worldwide, helping them navigate the ever-changing technology landscape and build solid tech foundations for their business. With its comprehensive offerings, global workforce, and strategic technology partnerships, Synoptek helps organizations grow their business while optimizing and protecting their IT ecosystem. With growth, ownership, inclusivity, and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders. Discover more at www.synoptek.com, or connect with Synoptek on Facebook, Twitter and LinkedIn.

Share This Post

We're Ready to Listen

Gener8 Celebrates 20 Years of Business and Continued Growth

News and Insights

Index

Gener8 Celebrates 20 Years of Business and Continued Growth

Sunnyvale, CA – September 16th, 2022 – Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), celebrates the company’s 20^th anniversary this month. Since its founding in September 2002 Gener8 has developed into a full product lifecycle engineering and manufacturing partner, successfully serving the biotech, life sciences, and medical device industries. “I feel lucky and honored by the team of amazing employees and customers that have assembled to make Gener8 what it is today. I had no idea when Gener8 started in my garage that it would grow to become a leading global life sciences company that it is now”, said David Klein, founder of Gener8. “None of this would have been possible without the dedicated team who shared a vision and worked tirelessly to achieve it”.

In recent years, Gener8 has expanded its core instrument engineering capabilities through strategic acquisitions in 2019, adding microfluidics cartridge design, development, and manufacturing, and in 2021, adding full lifecycle software development capabilities. Gener8 now offers comprehensive turnkey solutions for instrument, consumable, and software design, development, and manufacturing, under one roof. “These synergistic capabilities provide significant value to our clients by coordinating all aspects of a project, under one roof”, said Jerry Jurkiewicz, Gener8 CEO. “As an evolving company, the new Gener8 logo reflects the seamless connection we provide through each stage of the product lifecycle – from product development and launch through to manufacturing. Gener8 now offers a true end-to-end solution.”

Gener8 is continuing to expand its services by introducing a cost-competitive manufacturing site in Costa Rica in Q4 of this year. In addition, Gener8 will relocate their current company headquarters to a larger facility in San Jose. Gener8’s leadership anticipates continued growth and expansion thanks to the dedication of the entire staff to emerging technology and the trusted confidences of their clientele.

About Gener8

Gener8, founded in 2002, is a leading provider of turnkey design and manufacturing services specializing in high complexity products, primarily for medical device and diagnostics applications. Gener8 maintains state-of-the-art facilities and a world-class engineering team with more than 40 PhDs spanning a multitude of disciplines, including electrical, mechanical, software, optical and systems engineering. For more information, please visit www.gener8.net.

About Sverica Capital Management

Sverica Capital Management is a leading growth-oriented private equity firm that has raised over $1.1 billion across five funds. The firm acquires, invests in and actively builds companies that are, or could become, leaders in their industries. Since inception, Sverica has followed a “business builder” approach to investing and takes an active supporting role in its portfolio companies. Sverica devotes significant time and internal resources to help its management teams develop and execute growth strategies and proactively looks for levers to pull to accelerate growth by reinvesting back into those companies. Sverica firmly believes in building businesses collaboratively that can endure for the long term by starting with a strong foundation and bringing the right people and playbook to drive reinvestment and ultimately strong returns for our investors. For more information, please visit www.sverica.com.